Aktis Oncology Inc. (AKTS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-20
5:44 pm
Purchase
2026-01-1213DAKOUSTIS TECHNOLOGIES INC
AKTSQ
MPM BIOVENTURES 2018, L.P.10,260,064
19.300%
10,260,064increase
(New Position)
Filing
History
2026-01-20
2:01 pm
Purchase
2026-01-1213DAktis Oncology, Inc.
AKTS
EcoR1 Capital, LLC4,862,335
9.100%
4,862,335increase
(New Position)
Filing
History
2026-01-15
06:02 am
Purchase
2026-01-1213DAKOUSTIS TECHNOLOGIES INC
AKTSQ
ELI LILLY & Co
LLY
6,344,114
11.900%
6,344,114increase
(New Position)
Filing
History
2026-01-14
4:58 pm
Purchase
2026-01-1213DAktis Oncology, Inc.
AKTS
VV Manager II LLC5,831,315
10.900%
5,831,315increase
(New Position)
Filing
History